SCHEMBL9804865

SCHEMBL9804865

CCOCN1C(C)=C(C(=O)O)C(c2cccc(Cl)c2Cl)C(C(=O)OC)=C1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.57
TSHR P16473 3/20 0.57
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C19 P33261 2/20 0.57
KMT2A Q03164 2/20 0.57
HIF1A Q16665 2/20 0.57
HSD17B10 Q99714 2/20 0.57
ABCB11 O95342 2/20 0.57
LMNA P02545 2/20 0.57
GAA P10253 2/20 0.57
ALDH1A1 P00352 1/20 0.57
HPGD P15428 1/20 0.57
TP53 P04637 1/20 0.57
CYP2D6 P10635 1/20 0.57
NFKB1 P19838 1/20 0.57
THPO P40225 1/20 0.57
NR1I2 O75469 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9121989 0.93 CYP2C9 (0.49) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL9032779 0.90 CYP2C9 (0.57) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL10366225 0.88 TSHR (0.51) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL9032248 0.84 CYP2C9 (0.51) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL4790038 0.82 CYP2C9 (0.58) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL9234815 0.82 CYP2C9 (0.51) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL28802628 0.80 ABCB11 (0.63) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL9034239 0.79 CYP2C9 (0.58) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL8199258 0.79 TSHR (0.73) CYP2C9TSHRKDM4EMEN1CYP1A2
SCHEMBL4881545 0.79 LMNA (0.61) CYP2C9TSHRKDM4EMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994461-A Vasodilators; treating cardiovascular disorders BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1991-02-19 US disclosed
EP-0394243-A1 PROCESS FOR MANUFACTURING CARBOXYLIC ACIDS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1990-10-31 EP disclosed
EP-0343193-A1 1,4-DIHYDROPYRIDINE ENANTIOMERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1989-11-29 EP disclosed
EP-0296316-A1 1,4-Dihydropyridine enantiomers Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1988-12-28 EP disclosed
WO-1988009331-A1 PROCESS FOR MANUFACTURING CARBOXYLIC ACIDS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1988-12-01 WO disclosed
EP-0287828-A1 Intermediates and their preparation Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1988-10-26 EP disclosed
WO-1988007525-A1 1,4-DIHYDROPYRIDINE ENANTIOMERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1988-10-06 WO disclosed